Kata Szántó

16PUBLICATIONS
33CO-AUTHORS
Food properties (incl. characteristics and health benefits)Predictive and prognostic markersInnate immunityAutoimmunityMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 28, 2024
Shotgun Analysis of Gut Microbiota with Body Composition and Lipid Characteristics in Crohn's Disease.

Péter Bacsur, Tamás Resál, Bernadett Farkas

|Sep 26, 2023
Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases.

Boldizsár Jójárt, Tamás Resál, Diána Kata

|Jul 18, 2023
Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients following COVID-19 vaccination.

Tamás Resál, Péter Bacsur, Miklós Horváth

|Jun 16, 2023
Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls.

Péter Bacsur, Mariann Rutka, András Asbóth

|Feb 22, 2023
Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone.

Tamás Resál, Katalin Mangó, Péter Bacsur

|Jan 05, 2023
Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn's disease: results from a multicentre cohort study.

Péter Bacsur, Mária Matuz, Tamás Resál

Pageof 3

Frequent Collaborators

9 joint publications

Renáta Bor

8 joint publications

Anna Fábián

7 joint publications

Klaudia Farkas

7 joint publications

Ágnes Milassin